155 related articles for article (PubMed ID: 8521180)
1. Cyclic nucleotide phosphodiesterases from purified human CD4+ and CD8+ T lymphocytes.
Tenor H; Staniciu L; Schudt C; Hatzelmann A; Wendel A; Djukanović R; Church MK; Shute JK
Clin Exp Allergy; 1995 Jul; 25(7):616-24. PubMed ID: 8521180
[TBL] [Abstract][Full Text] [Related]
2. Cyclic nucleotide phosphodiesterase isoenzyme activities in human alveolar macrophages.
Tenor H; Hatzelmann A; Kupferschmidt R; Stanciu L; Djukanović R; Schudt C; Wendel A; Church MK; Shute JK
Clin Exp Allergy; 1995 Jul; 25(7):625-33. PubMed ID: 8521181
[TBL] [Abstract][Full Text] [Related]
3. Characterization and selective inhibition of cyclic nucleotide phosphodiesterase isozymes in canine tracheal smooth muscle.
Torphy TJ; Cieslinski LB
Mol Pharmacol; 1990 Feb; 37(2):206-14. PubMed ID: 2154670
[TBL] [Abstract][Full Text] [Related]
4. Isoenzyme-selective cyclic nucleotide phosphodiesterase inhibitors: effects on airways smooth muscle.
Raeburn D; Advenier C
Int J Biochem Cell Biol; 1995 Jan; 27(1):29-37. PubMed ID: 7757880
[TBL] [Abstract][Full Text] [Related]
5. Identification and quantification of phosphodiesterase 4 subtypes in CD4 and CD8 lymphocytes from healthy and asthmatic subjects.
Landells LJ; Szilagy CM; Jones NA; Banner KH; Allen JM; Doherty A; O'Connor BJ; Spina D; Page CP
Br J Pharmacol; 2001 Jul; 133(5):722-9. PubMed ID: 11429397
[TBL] [Abstract][Full Text] [Related]
6. Multiple high-affinity cAMP-phosphodiesterases in human T-lymphocytes.
Robicsek SA; Blanchard DK; Djeu JY; Krzanowski JJ; Szentivanyi A; Polson JB
Biochem Pharmacol; 1991 Jul; 42(4):869-77. PubMed ID: 1651080
[TBL] [Abstract][Full Text] [Related]
7. Phosphodiesterase (PDE) 7 in inflammatory cells from patients with asthma and COPD.
Jones NA; Leport M; Holand T; Vos T; Morgan M; Fink M; Pruniaux MP; Berthelier C; O'Connor BJ; Bertrand C; Page CP
Pulm Pharmacol Ther; 2007; 20(1):60-8. PubMed ID: 16427796
[TBL] [Abstract][Full Text] [Related]
8. Phosphodiesterase profiles of highly purified human peripheral blood leukocyte populations from normal and atopic individuals: a comparative study.
Gantner F; Tenor H; Gekeler V; Schudt C; Wendel A; Hatzelmann A
J Allergy Clin Immunol; 1997 Oct; 100(4):527-35. PubMed ID: 9338548
[TBL] [Abstract][Full Text] [Related]
9. The effect of cyclic AMP and cyclic GMP phosphodiesterase inhibitors on the superoxide burst of guinea-pig peritoneal macrophages.
Turner NC; Wood LJ; Burns FM; Gueremy T; Souness JE
Br J Pharmacol; 1993 Apr; 108(4):876-83. PubMed ID: 8387385
[TBL] [Abstract][Full Text] [Related]
10. KS-505a, an isoform-selective inhibitor of calmodulin-dependent cyclic nucleotide phosphodiesterase.
Ichimura M; Eiki R; Osawa K; Nakanishi S; Kase H
Biochem J; 1996 May; 316 ( Pt 1)(Pt 1):311-6. PubMed ID: 8645223
[TBL] [Abstract][Full Text] [Related]
11. Identification of cyclic AMP phosphodiesterases 3, 4 and 7 in human CD4+ and CD8+ T-lymphocytes: role in regulating proliferation and the biosynthesis of interleukin-2.
Giembycz MA; Corrigan CJ; Seybold J; Newton R; Barnes PJ
Br J Pharmacol; 1996 Aug; 118(8):1945-58. PubMed ID: 8864528
[TBL] [Abstract][Full Text] [Related]
12. Resolution of soluble cyclic nucleotide phosphodiesterase isoenzymes, from liver and hepatocytes, identifies a novel IBMX-insensitive form.
Lavan BE; Lakey T; Houslay MD
Biochem Pharmacol; 1989 Nov; 38(22):4123-36. PubMed ID: 2480793
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of human cardiac cyclic AMP-phosphodiesterases by R 80122, a new selective cyclic AMP-phosphodiesterase III inhibitor: a comparison with other cardiotonic compounds.
de Cheffoy de Courcelles D; de Loore K; Freyne E; Janssen PA
J Pharmacol Exp Ther; 1992 Oct; 263(1):6-14. PubMed ID: 1328613
[TBL] [Abstract][Full Text] [Related]
14. Characterization of cyclic nucleotide phosphodiesterases from cultured bovine aortic endothelial cells.
Lugnier C; Schini VB
Biochem Pharmacol; 1990 Jan; 39(1):75-84. PubMed ID: 2153383
[TBL] [Abstract][Full Text] [Related]
15. Differential modulation of cytokine production by drugs: implications for therapy in heart failure.
Matsumori A; Ono K; Sato Y; Shioi T; Nose Y; Sasayama S
J Mol Cell Cardiol; 1996 Dec; 28(12):2491-9. PubMed ID: 9004165
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the cyclic nucleotide phosphodiesterase subtypes involved in the regulation of the L-type Ca2+ current in rat ventricular myocytes.
Verde I; Vandecasteele G; Lezoualc'h F; Fischmeister R
Br J Pharmacol; 1999 May; 127(1):65-74. PubMed ID: 10369457
[TBL] [Abstract][Full Text] [Related]
17. Cyclic AMP and cyclic GMP phosphodiesterase activities in Hodgkin's disease lymphocytes.
Aleksijevic A; Lugnier C; Giron C; Mayer S; Stoclet JC; Lang JM
Int J Immunopharmacol; 1987; 9(5):525-31. PubMed ID: 3040609
[TBL] [Abstract][Full Text] [Related]
18. Pig aortic endothelial-cell cyclic nucleotide phosphodiesterases. Use of phosphodiesterase inhibitors to evaluate their roles in regulating cyclic nucleotide levels in intact cells.
Souness JE; Diocee BK; Martin W; Moodie SA
Biochem J; 1990 Feb; 266(1):127-32. PubMed ID: 2155604
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of a phosphodiesterase III in the lysis-sensitive target-induced elevation of cyclic AMP (cAMP) in human natural killer cells.
Whalen MM; Crews JD
Biochem Pharmacol; 2000 Aug; 60(4):499-506. PubMed ID: 10874124
[TBL] [Abstract][Full Text] [Related]
20. Porcine detrusor cyclic nucleotide phosphodiesterase isoenzymes: characterization and functional effects of various phosphodiesterase inhibitors in vitro.
Truss MC; Uckert S; Stief CG; Schulz-Knappe P; Hess R; Forssmann WG; Jonas U
Urology; 1995 May; 45(5):893-901. PubMed ID: 7747383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
